Skip to main content
. 2016 May 23;34(20):2333–2340. doi: 10.1200/JCO.2015.64.8899

Table A3.

Incidence of PE in At-Risk Dasatinib-Treated Patients by the Year They Were Reported in the Study

Year of Treatment No. of Patients at Risk No. of PE Incidents (%)
≤ 1 year 258 20 (8)
>1 to ≤ 2 years 209 13 (6)
>2 to ≤ 3 years 184 11 (6)
>3 to ≤ 4 years 160 14 (9)
>4 to ≤ 5 years 141 12 (9)

Abbreviation: PE, pleural effusion.